Bioactive Anti-Thrombotic Modification of Decellularized Matrix for Vascular Applications.

about

Improving in vivo outcomes of decellularized vascular grafts via incorporation of a novel extracellular matrix.Constructing heparin-modified pancreatic decellularized scaffold to improve its re-endothelialization.

P2860

Q47968195-039CD814-0881-4A66-90FA-D6F1966E86DB Q50025636-9F0935E8-EC42-45E6-B4BF-391319FDB8A7

P2860

Bioactive Anti-Thrombotic Modification of Decellularized Matrix for Vascular Applications.

Item

http://www.wikidata.org/entity/Q47126623

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@en

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@nl

type

Item

label

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@en

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@nl

prefLabel

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@en

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@nl

P1476

Bioactive Anti-Thrombotic Modi ...... rix for Vascular Applications.

@en

P2093

Monica T Hinds

http://www.w3.org/2001/XMLSchema#string

P2860

Capture of endothelial cells under flow using immobilized vascular endothelial growth factor

The cytoprotective protein C pathway

The dynamics of thrombin formation

Heparin-coated stents.

Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities.

Low-molecular-weight heparins.

Engineering an endothelialized vascular graft: a rational approach to study design in a non-human primate model.

Endothelial outgrowth cells regulate coagulation, platelet accumulation, and respond to tumor necrosis factor similar to carotid endothelial cells.

Crosslinking decreases the hemocompatibility of decellularized, porcine small intestinal submucosa.

Decellularized tissue-engineered blood vessel as an arterial conduit

P304

1439-1446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADHM.201600020

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy J. Glynn

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27072858

http://www.w3.org/2001/XMLSchema#string

P932

5753589

http://www.w3.org/2001/XMLSchema#string

Bioactive Anti-Thrombotic Modification of Decellularized Matrix for Vascular Applications.

about

P2860

P2860

Bioactive Anti-Thrombotic Modification of Decellularized Matrix for Vascular Applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932